AMG 691
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG 691, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma [Phase 1]